Sai Life Sciences Ltd

Sai Life Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sai Life Sciences Ltd

₹ 998 3.50%
27 Feb - close price
sailife.com BSE: 544306 NSE: SAILIFE
About

Incorporated in 1999, Sai Life Sciences
Ltd carries out contract research and manufacturing activities for customers
engaged in pharmaceutical and bio
technology industries[1]

Key Points

Business Profile[1]
Sai Life Sciences is an integrated CRDMO (Contract Research, Development and Manufacturing Organization) delivering end-to-end services across the pharmaceutical lifecycle from early drug discovery to commercial manufacturing.

Website BSE NSE
  • Market Cap ₹ 21,140 Cr.
  • Current Price ₹ 998
  • High / Low ₹ 1,005 / 635
  • Stock P/E 62.3
  • Book Value ₹ 107
  • Dividend Yield 0.00 %
  • ROCE 14.0 %
  • ROE 11.0 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is expected to give good quarter

Cons

  • Stock is trading at 9.29 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 7.86% over last 3 years.
  • Working capital days have increased from 37.8 days to 66.4 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE 500 BSE Healthcare Nifty 500 BSE Allcap BSE 250 SmallCap Index

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
384 439 280 396 440 580 496 537 556
287 315 254 293 320 422 375 392 369
Operating Profit 96 125 26 102 120 158 121 146 188
OPM % 25% 28% 9% 26% 27% 27% 24% 27% 34%
11 3 8 10 9 10 10 15 0
Interest 23 21 21 21 23 11 12 9 10
Depreciation 31 31 31 36 34 37 38 40 44
Profit before tax 53 76 -18 55 72 119 81 112 134
Tax % 25% 26% -25% 25% 25% 26% 25% 25% 25%
40 56 -14 42 54 88 60 84 100
EPS in Rs 2.59 4.24 2.90 4.00 4.75
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
695 726 760 870 1,217 1,465 1,695 2,170
520 558 593 743 1,048 1,178 1,285 1,558
Operating Profit 176 168 167 126 169 287 410 612
OPM % 25% 23% 22% 15% 14% 20% 24% 28%
6 18 27 28 27 29 35 35
Interest 24 22 33 54 81 88 78 42
Depreciation 44 55 80 90 99 119 139 159
Profit before tax 113 109 82 10 16 109 228 446
Tax % 35% 30% 25% 36% 39% 24% 25%
73 76 61 6 10 83 170 333
EPS in Rs 8.16 15.89
Dividend Payout % 0% 0% 0% 1,116% 676% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 18%
3 Years: 25%
TTM: 40%
Compounded Profit Growth
10 Years: %
5 Years: 18%
3 Years: 229%
TTM: 146%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 45%
Return on Equity
10 Years: %
5 Years: 6%
3 Years: 8%
Last Year: 11%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 16 16 17 18 18 18 21 21
Reserves 703 778 845 861 870 957 2,108 2,249
249 304 637 752 933 928 352 418
247 312 318 527 358 359 665 644
Total Liabilities 1,215 1,410 1,817 2,157 2,179 2,262 3,146 3,332
373 641 701 751 1,037 1,180 1,488 1,622
CWIP 116 91 246 410 151 107 124 115
Investments 0 0 0 0 2 2 2 2
726 679 870 997 989 973 1,531 1,592
Total Assets 1,215 1,410 1,817 2,157 2,179 2,262 3,146 3,332

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
129 116 -36 105 219 263 314
-158 -262 -260 -102 -99 -191 -536
268 -4 296 72 -201 -95 301
Net Cash Flow 239 -150 -1 75 -80 -24 79

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 123 136 99 102 85 64 76
Inventory Days 86 79 127 179 121 72 93
Days Payable 207 258 230 279 180 113 253
Cash Conversion Cycle 1 -43 -4 2 25 22 -83
Working Capital Days 55 24 62 42 36 12 66
ROCE % 13% 9% 3% 6% 11% 14%

Shareholding Pattern

Numbers in percentages

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
35.23% 35.16% 35.15% 34.95% 34.70%
11.72% 12.36% 14.57% 22.50% 21.41%
11.95% 13.26% 21.64% 29.92% 31.41%
41.08% 39.21% 28.64% 12.65% 12.49%
No. of Shareholders 1,81,1221,40,6771,26,3801,19,7051,14,820

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls